Acute Kidney Injury (AKI) — AKI: prerenal, intrarenal, and postrenal mechanisms

The recognition that kidneys can fail acutely—over hours to days rather than months to years—has evolved dramatically over the past century. During World War I, physicians observed soldiers who survived crush injuries only to die from what was then called war nephritis, a mysterious shutdown of urine production accompanied by uremia and death. The condition puzzled clinicians because the kidneys appeared structurally intact at autopsy, suggesting a functional rather than purely anatomical process. It was not until the battlefield medicine of World War II that Homer W. Smith and others began systematically studying the pathophysiology of acute renal failure, eventually categorizing it into distinct mechanistic subtypes that remain foundational to modern nephrology.

Today, AKI affects approximately 10–15% of all hospitalized patients and up to 50% of critically ill patients in intensive care units. Its in-hospital mortality can exceed 50% when dialysis is required, making rapid identification of the underlying mechanism—prerenal, intrarenal (intrinsic), or postrenal—essential for selecting the correct therapeutic strategy. The central question driving this lesson is: How do we determine where along the renal perfusion–filtration–drainage axis the injury has occurred, and why does this distinction dictate entirely different management approaches?

Acute kidney injury (AKI) is defined as a sudden decline in renal function occurring over hours to days, characterized by an increase in serum creatinine of ≥ 0.3 mg/dL within 48 hours, a rise to ≥ 1.5 × baseline within 7 days, or a urine output of < 0.5 mL/kg/hr for 6 hours. The pathophysiology of AKI is organized around the anatomical location of the insult relative to the kidney itself, yielding three mechanistic categories: prerenal, intrarenal (intrinsic), and postrenal. Each category involves fundamentally different mechanisms, produces distinct laboratory patterns, and demands a unique therapeutic approach.

The diagram above organizes AKI by the anatomical site of the insult. Notice that prerenal causes all share the theme of reduced renal blood flow—whether from volume depletion, pump failure, or inappropriate vasodilation—while the nephron itself remains structurally normal. The intrarenal column reveals a more heterogeneous group: damage can target the tubules (ATN), the glomeruli (glomerulonephritis), the interstitium (AIN), or the renal vasculature. Postrenal etiologies all produce obstruction to urine outflow, and their hallmark imaging finding is hydronephrosis on renal ultrasound. Understanding these categories is not merely academic—each demands a fundamentally different therapeutic intervention, from fluid resuscitation in prerenal AKI to nephrotoxin withdrawal in intrinsic AKI to catheter placement or surgical decompression in postrenal AKI.

Prerenal Mechanism: The Hemodynamic Crisis

The kidney receives approximately 20–25% of cardiac output, making it exquisitely sensitive to hemodynamic compromise. In prerenal AKI, the glomerular filtration rate (GFR) declines because the net filtration pressure across the glomerular capillaries drops. Under normal conditions, the kidney maintains GFR relatively constant through autoregulation—afferent arteriolar dilation mediated by prostaglandins and efferent arteriolar constriction mediated by angiotensin II. However, when mean arterial pressure (MAP) falls below approximately 65–70 mmHg, autoregulatory mechanisms are exhausted and GFR declines in direct proportion to perfusion pressure. Because the tubular epithelium remains intact, the nephron responds appropriately by avidly reabsorbing sodium and water, producing concentrated, sodium-poor urine.

Intrarenal Mechanism: Parenchymal Destruction

Intrarenal AKI arises when the injury directly damages the renal parenchyma. The most common form is acute tubular necrosis (ATN), which occurs through either ischemic or nephrotoxic pathways. In ischemic ATN, prolonged prerenal hypoperfusion causes the metabolically active tubular epithelial cells—particularly in the S3 segment of the proximal tubule and the medullary thick ascending limb—to undergo necrosis or apoptosis. These segments are vulnerable because they reside in the relatively hypoxic outer medulla, where oxygen tension normally hovers near 10–20 mmHg. Nephrotoxic ATN is caused by direct cellular toxicity from agents such as aminoglycosides, radiocontrast dye, cisplatin, or endogenous pigments like myoglobin and hemoglobin. Damaged tubular cells slough into the lumen, forming muddy brown granular casts that are pathognomonic on urinalysis. The loss of tubular integrity means the nephron can no longer concentrate urine or reabsorb sodium effectively, producing a FE_Na > 2%.

Postrenal Mechanism: Obstructive Backpressure

Postrenal AKI occurs when bilateral urinary outflow obstruction—or unilateral obstruction in a patient with a single functioning kidney—raises intratubular hydrostatic pressure sufficiently to oppose glomerular filtration. Recall that the net filtration pressure driving GFR equals the glomerular capillary hydrostatic pressure minus both the Bowman capsule hydrostatic pressure and the glomerular capillary oncotic pressure. Obstruction raises the Bowman capsule pressure term (P_BS), thereby reducing net filtration pressure and ultimately GFR. Common etiologies include benign prostatic hyperplasia (BPH) in older men, bilateral ureteral stones, pelvic malignancies causing extrinsic ureteral compression, and neurogenic bladder. The diagnostic hallmark is hydronephrosis visible on renal ultrasound, and treatment centers on relieving the obstruction—via Foley catheter for bladder outlet obstruction, ureteral stents, or percutaneous nephrostomy.

Distinguishing prerenal from intrinsic renal AKI is one of the most clinically consequential diagnostic tasks in nephrology. The two entities share the same presentation—rising creatinine and often oliguria—but their management is diametrically opposed: prerenal AKI demands volume expansion and perfusion optimization, while administering aggressive fluids to a patient with established ATN risks volume overload and pulmonary edema. Fortunately, several laboratory indices exploit the fact that intact tubules in prerenal AKI avidly reabsorb sodium and concentrate urine, while damaged tubules in intrinsic AKI lose these capacities.

A 72-year-old male with a history of heart failure is admitted with 3 days of vomiting and diarrhea. His baseline creatinine is 1.0 mg/dL. On admission, his serum creatinine is 2.8 mg/dL, BUN is 56 mg/dL, serum sodium is 140 mEq/L, heart rate is 110 bpm, and blood pressure is 85/50 mmHg. Urinalysis shows no casts and specific gravity of 1.030. Spot urine studies reveal: urine sodium = 8 mEq/L and urine creatinine = 120 mg/dL. Renal ultrasound shows no hydronephrosis. Classify the AKI and calculate the FE_Na.

While the prerenal–intrinsic–postrenal framework is clinically indispensable, it has important limitations that clinicians must recognize. The classification system implies discrete categories, but in reality AKI often represents a continuum—prolonged prerenal hypoperfusion, if not corrected, transitions into ischemic ATN, making the boundary between prerenal and intrinsic AKI a moving target rather than a fixed line. Additionally, certain diagnostic indices have well-documented exceptions that can mislead clinicians who apply them too rigidly.

Historically, AKI was considered a fully reversible condition—once the insult resolved, renal function was expected to return to baseline. This paradigm has been fundamentally challenged by large epidemiologic studies showing that even a single episode of AKI significantly increases the risk of developing chronic kidney disease (CKD), progression to end-stage renal disease (ESRD), and long-term cardiovascular mortality. The mechanism connecting AKI to CKD involves maladaptive repair processes: after tubular necrosis, regenerating epithelial cells may undergo cell-cycle arrest at the G2/M checkpoint, acquiring a pro-fibrotic secretory phenotype that promotes interstitial fibrosis and progressive nephron loss through a process sometimes termed the AKI-to-CKD transition.

Advanced research has also reframed cardiorenal syndrome and hepatorenal syndrome as specialized forms of prerenal AKI driven by organ-specific hemodynamic derangements. In cardiorenal syndrome type 1, acute heart failure causes venous congestion and reduced arterial perfusion of the kidneys simultaneously—a dual insult that standard FE_Na calculations may not fully capture. Similarly, hepatorenal syndrome involves extreme splanchnic vasodilation in advanced cirrhosis, redirecting blood away from the kidneys despite a normal or elevated total blood volume. These advanced contexts illustrate that the prerenal–intrinsic–postrenal framework, while powerful, must be applied within the patient's full clinical picture.